以皮肤黏膜淋巴结改变为首发症状的ALK阳性间变性大细胞淋巴瘤1例报告及文献复习

doi:10.13481/j.1671-587x.20190640

吉林大学学报(医学版) ›› 2019, Vol. 45 ›› Issue (06): 1432-1435.doi: 10.13481/j.1671-587x.20190640

以皮肤黏膜淋巴结改变为首发症状的ALK阳性间变性大细胞淋巴瘤1例报告及文献复习

王瑜¹, 蒋鑫萍², 常健¹, 曲超³, 韩冬冰⁴

1. 吉林大学第一医院小儿肿瘤科, 吉林长春 130021;
2. 吉林大学第一医院联合超声科, 吉林长春 130021;
3. 吉林大学第一医院放疗科, 吉林长春 130021;
4. 吉林省一汽总医院信息技术科, 吉林长春 130011

收稿日期:2018-12-05 出版日期:2019-12-05 发布日期:2019-12-05
通讯作者: 蒋鑫萍,主治医师(Tel:0431-88783934,E-mail:jxp@jlu.edu.com) E-mail:jxp@jlu.edu.com
作者简介:王瑜(1987-),女,吉林省长春市人,主治医师,医学硕士,主要从事儿童淋巴瘤诊治方面的研究。
基金资助:
国家自然科学基金青年基金资助课题（8170274）

ALK-positive anaplastic large cell lymphoma with changes in skin mucosal lymph nodes as first symptom: A case report and literature review

WANG Yu¹, JIANG Xinping², CHANG Jian¹, QU Chao³, HAN Dongbing⁴

1. Department of Pediatric Oncology, First Hospital, Jilin University, Changchun 130021, China;
2. Department of Ultrasound, First Hospital, Jilin University, Changchun 130021, China;
3. Department of Radiotherapy, First Hospital, Jilin University, Changchun 130021, China;
4. Department of Information Technology, Jilin FAW General Hospital, Changchun 130011, China

Received:2018-12-05 Online:2019-12-05 Published:2019-12-05

摘要/Abstract

摘要： 目的：分析儿童间变性大细胞淋巴瘤（ALCL）的临床特点、诊断标准和治疗方法，提高临床医生对该病的诊疗水平。方法：回顾性分析1例ALCL患儿的临床资料，包括临床症状、体征、辅助检查、诊断依据、鉴别诊断、治疗方案和疾病转归等，并结合文献复习总结该病的诊治要点。结果：该患儿以颈部淋巴结进行性增大为主要症状就诊，查体口唇殷红，表皮皲裂；周身皮肤干燥，以双手为著，掌心可见皲裂，指端可见膜状脱屑；双颈部见多个肿大淋巴结，边界不清，活动度差，伴压痛；舌乳头呈草莓舌。活检病理，ALK阳性ALCL；骨髓涂片未见异常；骨髓免疫分型、外周血免疫分型和脑脊液免疫分型均可见异常表型T淋巴细胞。按照《国际儿童非霍奇金淋巴瘤分期系统（2012年）》，该患儿明确诊断为ALK阳性ALCL （Ⅳ期，R3组）。给予APO方案诱导化疗后评估患者病情达部分缓解（PR），更换治疗方案为B-NHL-BFM-90方案；经过1个周期改良AA方案治疗后，患者骨髓和外周血免疫分型均转阴。结论：ALCL患儿的临床表现多样化，淋巴结活检是确诊ALCL的唯一依据，在明确诊断前不应盲目使用激素。

关键词: 间变性淋巴瘤激酶, 间变性大细胞淋巴瘤, T淋巴细胞, 淋巴结活检, 骨髓免疫分型

Abstract: Objective: To analyze the clinical characteristics, diagnostic criteria and treatment methods of the children with degenerative large cell lymphoma (ALCL), and to improve the diagnosis and treatment level of the clinicians. Methods: The clinical data of one child with ALCL were retrospectively analyzed, including clinical symptoms, signs, auxiliary examination, diagnosis basis, differential diagnosis, treatment plan and disease outcome,and the key factors of diagnosis and treatment of the disease were summarized combined with literature review. Results: The child went to hospital because of progressive lymph node enlargement as the first symptom. The lips were red, the epidermis was cleft, the skin was dry, both hands were prominent, and the palm was cleft and the flaky desquamation was visible on the fingertips;multiple swollen lymph nodes were found on the sides of neck, the boundary was unclear, the activity was poor,and tenderness was also found; the tongue nipple presented strawberry tongue. The biopsy pathological results showed ALK-positive ALCL. There were no abnormalities in the bone marrow smear; the abnormal phenotypic T lymphocytes were found in the bone marrow immunotype, peripheral blood immunotype and cerebrospinal fluid immunotype. According to the International Childhood Non-Hodgkin's Lymphoma Staging System (2012),the chlid was clearly diagnosed as ALK-positive ALCL (stage Ⅳ, R3 group).After the induction chemotherapy of APO regimen was given, the condition of the patient was up to partial remission(PR),and the treatment regimen was replaced with B-NHL-BFM-90 regimen; after one cycle of modified AA regimen, the bone marrow and peripheral blood immunotype of the patient turned negative. Conclusion: The clinical manifestations of ALCL patients are different; the lymph node biopsy is the only basis for the diagnosis of ALCL,and hormones could not be blindly used before definitive diagnosis.

Key words: biopsy, bone marrow immunotype, anaplastic lymphoma kinase, anaplastic large cell lymphoma, T lymphocyte, lymph node

中图分类号:

R725.5

王瑜, 蒋鑫萍, 常健, 曲超, 韩冬冰. 以皮肤黏膜淋巴结改变为首发症状的ALK阳性间变性大细胞淋巴瘤1例报告及文献复习[J]. 吉林大学学报(医学版), 2019, 45(06): 1432-1435.

WANG Yu, JIANG Xinping, CHANG Jian, QU Chao, HAN Dongbing. ALK-positive anaplastic large cell lymphoma with changes in skin mucosal lymph nodes as first symptom: A case report and literature review[J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1432-1435.

参考文献

[1] STEIN H,MASON D Y,GERDES J,et al.The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue:evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells[J].Blood,1985,66(4):848-858.
[2] HARRIS N L,JAFFE E S,STEIN H,et al.A revised European-American classification of lymphoid neoplasms:A proposal from the International Lymphoma Study Group[J].Blood,1994,84(5):1361-1392.
[3] KADIN M E.Anaplastic large cell lymphoma and its morphological variants[J].Cancer Surv,1997,30:77-86.
[4] PILERI S,FALINI B,DELSOL G,et al.Lymphohistiocytic T-cell lymphoma(anaplastic large cell lymphoma CD30⁺/Ki-1⁺ with a high content of reactive histiocytes) [J].Histopathology,1990,16(4):383-391.
[5] KINNEY M C,COLLINS R D,GREER J P,et al.A small-cell-predominant variant of primary Ki-1(CD30⁺)T-cell lymphoma[J].Am J Surg Pathol,1993,17(9):859-868.
[6] 魏婵娟,赵强.ALK与儿童恶性肿瘤关系的研究进展[J].中国肿瘤临床,2015,42(4):251-253.
[7] EYRE T A,KHAN D,HALL G W,et al.Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma:current and future perspectives in adult and paediatric disease[J].Eur J Haematol,2014,93(6):455-468.
[8] SWERDLOW S H, CAMPO E, HARRIS N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Lyon:LARC Press,2008:312-316.
[9] ALLEN C E,KELLY K M,BOLLARD C M.Pediatric lymphomas and histiocytic disorders of childhood[J].Pediatr Clin North Am,2015,62(1):139-165.
[10] 杨菁,赵晓曦,金铃,等.间变性大小淋巴瘤患儿骨髓及外周血NPM-ALK融合基因表达与预后的关系[J].中华血液学杂志,2013,34(8):700-703.
[11] LE DELEY M C,ROSOLEN A,WILLIAMS D M,et al.Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma:results of the randomized ALCL99-vinblastine trial[J]. J Clin Oncol,2010,28(25):3987-3933.
[12] SUN X F,ZHEN Z J,LIN S X,et al.Treatment outcome of Chinese children with anaplastic large cell lymphoma by using a modified B-NHL-BFM-90 protocol[J].Pediatr Hematol Oncol,2014,31(6):518-527.
[13] MAHUAD C V, REPARAZ M D E L, ZERGA M E, et al. Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib[J]. Rare Tumors, 2016,8(2):6266.
[14] SULLIVAN I, PLANCHARD D. ALK inhibitors in non-small cell lung cancer: the latest evidence and developments[J].Ther Adv Med Oncol, 2016,8(1):32-47.
[15] CLEARY J M, RODIG S, BARR P M, et al. Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma[J]. J Natl Compr Canc Netw,2014,12(3):323-326;quiz326.
[16] MOSSÉ Y P,LIM M S,VOSS S D,et al.Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a children’s Oncology Group phase 1 consortium study[J].Lancet Oncol,2013,14(6): 472-480.
[17] 杨菁,张永红,段彦龙.儿童间变性大细胞淋巴瘤31例误诊分析[J].实用儿科临床杂志,2008,23(15):1176-1178.
[18] 杨景柯,朱兴虎,左文丽,等.间变性大细胞淋巴瘤(ALK阳性)误诊为横纹肌肉瘤1例并文献复习[J].中国医药导报,2013,10(3):109-111.

以皮肤黏膜淋巴结改变为首发症状的ALK阳性间变性大细胞淋巴瘤1例报告及文献复习

ALK-positive anaplastic large cell lymphoma with changes in skin mucosal lymph nodes as first symptom: A case report and literature review

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	冯秀南, 袁艺, 宿凯笙, 姜振宇. 系统性红斑狼疮患者外周血T淋巴细胞亚群的分布及其与疾病活动和预后的关系[J]. 吉林大学学报(医学版), 2019, 45(06): 1415-1421.
[2]	褚金龙, 邢桂芝, 沈春瑾, 刘鑫颖, 褚智君. 三七总皂苷对再生障碍性贫血小鼠T淋巴细胞亚群的影响及其促造血作用[J]. 吉林大学学报(医学版), 2019, 45(04): 807-812.
[3]	王天玥, 周倩兰, 尚云晓. 表没食子儿茶素没食子酸酯对肥胖型哮喘小鼠气道炎症和Treg/Th17免疫平衡的影响[J]. 吉林大学学报(医学版), 2019, 45(03): 491-497.
[4]	王治国, 刘学明, 周云涛, 佟胜全, 李雅娟, 王茜, 陈南芳. 滋阴补肾方联合糖皮质激素对系统性红斑狼疮小鼠T淋巴细胞亚群和炎症细胞因子的影响[J]. 吉林大学学报(医学版), 2019, 45(02): 336-341.
[5]	方艳秋, 米旭光, 李首庆, 魏海峰, 许淑芬, 谭岩. 重组鼠白细胞介素18在肝癌小鼠体内的抗肿瘤作用[J]. 吉林大学学报(医学版), 2017, 43(03): 550-554.
[6]	刘薇薇, 张晓莉, 王晓非. 系统性红斑狼疮伴人巨细胞病毒IgM抗体阳性与阴性患者的临床特征比较[J]. 吉林大学学报(医学版), 2016, 42(06): 1178-1182.
[7]	樊锐太, 张恒, 王鑫, 顾浩. 胶质瘤患者T淋巴细胞表面CTLA-4的表达及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(02): 311-315.
[8]	刘红梅, 杨莉. 子宫切除术前给予右美托咪定对患者应激和免疫功能的影响[J]. 吉林大学学报(医学版), 2015, 41(06): 1245-1248.
[9]	拉宗，王建霞，崔倪，李明月，邢树刚，任博，张丽红，李伟，李玉林. 乳腺浸润性导管癌微环境中CD4和CD8阳性T细胞表达与 血管新生的关联性分析[J]. 吉林大学学报(医学版), 2014, 40(05): 1064-1073.
[10]	左凌云, 赵伟, 赵红, 俞海英, 孙薇薇. H1N1患者疾病早期CD4+T细胞减少及其临床意义[J]. J4, 2010, 36(5): 979-981.
[11]	武宁，王珍琦，李鹏武，吕杰，刘继顺，张萱. X射线对Jurkat和EL-4细胞周期进程的影响[J]. J4, 2008, 34(5): 729-732.
[12]	吴春风，马忠森，王秀丽，杨广民，马寅芙，杨俊玲，尹金植，陈鹏. 特发性肺纤维化患者外周血单个核细胞T淋巴细胞亚群及Th1/Th2型细胞因子的检测[J]. J4, 2008, 34(2): 282-284.
[13]	方艳秋，齐亚灵，严莉，谭岩，段秀. IL-12与IL-18在体外培养系统中诱导肿瘤特异性CTL杀伤活性的比较[J]. J4, 2007, 33(6): 1033-1037.
[14]	赵毅，于铁成，金安，刘建国，郑学清，徐莘香. p38 MAPK对冲击波促进T淋巴细胞增殖和分泌IL-2的作用[J]. J4, 2007, 33(5): 815-819.
[15]	付彤,李嗣杰,宋东，范志民. 艾易舒注射液在乳腺癌术后辅助治疗中的应用及效果评价[J]. J4, 2007, 33(4): 744-746.